INVESTORS

FUNDING

The company has been funded by the founders and angel investors, as well as with a grant from the Massachusetts Life Science Center and M2D2.  The team has been able to prototype, demonstrate, and protect the core principles of the technology.  Cre8MDI is in search of an infusion of capital to complete in-vivo testing devices and a hospital monitoring interface for patient testing. Contact us: cre8info@cre8mdi.com

INTELLECTUAL PROPERTY

Cre8MDI continues to grow its intellectual property portfolio worldwide.  Our proprietary technology resides in the signal processing algorithms, the sensor design, and the “ease of use” technology utilized to administer the diagnostic exam. Many provisional and utility applications containing numerous inventions have been filed.  It is anticipated that more patents will be submitted in the future. Some of the inventions are not only applicable to the present and future efforts of the company, but may also be beneficial to other companies outside of the area of arterial stiffness. These inventions may be licensed to other companies for increased revenue.  

 

A SPECIAL NOTE ABOUT FORWARD LOOKING STATEMENTS

We have made forward-looking statements on this website that are based on our management’s beliefs and assumptions and on information currently available to our management.  Forward-looking statements include the information concerning our possible or assumed future results of operations, business strategies, financing plans, competitive position, industry environment, potential growth opportunities, the effects of future regulation, and the effects of competition. Forward-looking statements include all statements that are not historical facts and can be identified by the use of forward-looking terminology such as the words “believe,” “expect,” “anticipate,” “intend,” “plan,” “estimate” or similar expressions.  

These statements are only predictions and involve known and unknown risks and uncertainties.

Although we believe that the expectations reflected in our forward-looking statements are reasonable, we cannot guarantee future results, events, levels of activity, performance or achievement. We are not under any duty to update any of the forward-looking statements after the date of this prospectus to conform these statements to actual results, unless required by law. Information on this website does not constitute an offer to purchase or a solicitation of an offer to purchase securities.